Showing results (191-200 of 237) with videos related to
Sort By:
Pageof 24
Bone Marrow Transplantation|October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTPatryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.Bone Marrow Transplantation|November 29, 2025
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working PartyMarta Villalba, Allain-Thibeault Ferhat, Tobias Gedde-Dahl, et al.Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.Bone Marrow Transplantation|April 7, 2021
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMTMitja Nabergoj, Katya Mauff, Marie Robin, et al.Bone Marrow Transplantation|July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMTSimona Iacobelli, Stefan Schönland, Linda Koster, et al.American Journal of Hematology|November 28, 2024
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMTThomas Luft, Luuk Gras, Linda Koster, et al.Bone Marrow Transplantation|June 4, 2024
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working partyJean El Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, et al.Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.Pageof 24